资讯

U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant GlaxoSmithKline ...
Doctors and patients should rigorously evaluate diagnosis and treatment compliance before turning to biologics, two ...
Democratic U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant ...
Medical experts are dismayed over a federal report's claim that kids are overprescribed asthma medications, saying it ...
GSK (GSK) faces an investigation from U.S. Senator Maggie Hassan over its decision to discontinue Flovent HFA asthma inhaler ...
The study suggests that digital inhalers may reduce the incidence of severe asthma exacerbations, particularly in patients at ...
The GINA 2025 asthma update includes new guidance on T2 biomarkers, asthma in young children, and climate change, as well as ...
There’s a reason your deodorant comes with a warning label: keep away from heat and hot surfaces. Compressed gases – like the ...
Cambridge-based start-up rolls out industry-first inhaler for delivering large amounts of drug in a single inhalation, enabling next-gen inhaled biologics for novel therapiesCAMBRIDGE, 24 June 2025: ...
Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions.
A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm ...
This updated asthma guideline establishes a consistent approach to improving asthma diagnosis and control in adults and ...